» Articles » PMID: 39639411

Microfluidic Biosensors for Biomarker Detection in Body Fluids: a Key Approach for Early Cancer Diagnosis

Overview
Journal Biomark Res
Publisher Biomed Central
Date 2024 Dec 5
PMID 39639411
Authors
Affiliations
Soon will be listed here.
Abstract

Early detection of cancer significantly improves patient outcomes, with biomarkers offering a promising avenue for earlier and more precise diagnoses. Microfluidic biosensors have emerged as a powerful tool for detecting these biomarkers in body fluids, providing enhanced sensitivity, specificity, and rapid analysis. This review focuses on recent advances in microfluidic biosensors from 2018 to 2024, detailing their operational principles, fabrication techniques, and integration with nanotechnology for cancer biomarker detection. Additionally, we have reviewed recent innovations in several aspects of microfluidic biosensors, such as novel detection technologies, nanomaterials and novel microfluidic chip structures, which significantly enhance detection capabilities. We highlight key biomarkers pertinent to early cancer detection and explore how these innovations in biosensor technology contribute to the evolving landscape of personalized medicine. We further explore how these technologies could be incorporated into clinical cancer diagnostic workflows to improve early detection and treatment outcomes. These innovations could help enable more precise and personalized cancer diagnostics. In addition, this review addresses several important issues such as enhancing the scalability and sensitivity of these biosensors in clinical settings and points out future possibilities of combining artificial intelligence diagnostics with microfluidic biosensors to optimize their practical applications. This overview aims to guide future research and clinical applications by addressing current challenges and identifying opportunities for further development in the field of biomarker research.

References
1.
Yang X, Zhang Q, Zhang M, Su W, Wang Z, Li Y . Serum microRNA Signature Is Capable of Early Diagnosis for Non-Small Cell Lung Cancer. Int J Biol Sci. 2019; 15(8):1712-1722. PMC: 6643220. DOI: 10.7150/ijbs.33986. View

2.
Wu C, Huang Y, Chen P, Hoshino K, Liu H, Frenkel E . Versatile immunomagnetic nanocarrier platform for capturing cancer cells. ACS Nano. 2013; 7(10):8816-23. PMC: 3846426. DOI: 10.1021/nn403281e. View

3.
Frick C, Rumgay H, Vignat J, Ginsburg O, Nolte E, Bray F . Quantitative estimates of preventable and treatable deaths from 36 cancers worldwide: a population-based study. Lancet Glob Health. 2023; 11(11):e1700-e1712. PMC: 10581909. DOI: 10.1016/S2214-109X(23)00406-0. View

4.
Juul S, Nielsen C, Labouriau R, Roy A, Tesauro C, Jensen P . Droplet microfluidics platform for highly sensitive and quantitative detection of malaria-causing Plasmodium parasites based on enzyme activity measurement. ACS Nano. 2012; 6(12):10676-83. PMC: 3528816. DOI: 10.1021/nn3038594. View

5.
Trinh K, Chae W, Lee N . Pressure-Free Assembling of Poly(methyl methacrylate) Microdevices via Microwave-Assisted Solvent Bonding and Its Biomedical Applications. Biosensors (Basel). 2021; 11(12). PMC: 8699324. DOI: 10.3390/bios11120526. View